If you want to know Bionaturis’ latests news, here you are our July newsletter

 

Imagen Bionaturis Newsletter

IN THIS ISSUE

  • Juan Juarez buys 5% of Bionaturis and Rafael Contreras increases his position
  • Bionaturis develops a breakthrough drug for livestock
  • Bionaturis Group enhances its international alliances in San Diego (USA)
  • Bionaturis shares start quoting in the continuous system on the MAB

Let’s get to know…

Cristina Infante Viñolo, 33 years old, born in La Linea de la Concepcion, degree in Chemistry at Cadiz University.

 

 

Cristina Infante

  • -When you were a child, what did you want to be as an adult?
  • A pediatrician or a veterinary surgeon.
  • -What do you like the most about your job?
  • Thinking that our job is able to improve somenone’s life in the future.
  • -What are your future challenges?
  • Rising my daughter Julia.
  • -Your favourite dish
  • A sandwich from the Brighton in the beach with my partner.
  • -A place
  • The sunrise of the Levante beach in La Linea de la Concepcion.
  • -A film
  • “The best youth”, by Marco Tullio Giordana.
  • -A historical figure
  • Any women who has fought for her freedom.
  • -A book
  • ‘The bad girl’, by Mario Vargas Llosa.
  • -A song
  • ‘Qué sabe nadie’, by Raphael.
  • -What do you usually do in your free time?
  • Enjoying of my little great family.
  • -A proposal to get rid of the crisis
  • Education and civil responsability, it is necessary a change of mentality about the concept of the State, where we are and how we are contributing inside this State, keeping always the respect and the neighbor’s well-being in mind. I think is as easy as everybody have lost the respect to the rest.
  • -How do you imagine the world in 20 years?
  • With social equality, 0% unemployment and without gender violence. That is how I want to imagine it.
  Cristina has been working in Bionturis since December 2008 as a Technician of Technological Development.

Juan Juarez buys 5% of Bionaturis and Rafael Contreras increases his position

The strong Bionaturis (BNT. MC) commitment of consolidating its international growth strategy, presence and professionalization in the financial markets has become real with the appointment of Juan Juarez as a Board Member since last June, 30. As part of the operation, Juarez has acquired 5% of the biotech […] Read more

Bionaturis develops a breakthrough drug for livestock

Bionaturis (ticker BNT-MAB), an international reference company providing biological drugs, has just signed a new collaborative agreement with a multinational company to develop a new product that meets an increasing need of the livestock industry. It is a new first-in-class drug to induce ovulation in livestock prior to artificial insemination […] Read more

Bionaturis Group enhances its international alliances in San Diego (USA)

Bionaturis and BBD Biophenix have taken part in the latest edition of Bio International Convention 2014, in San Diego (June 2014), where the hard-working days have strengthened the international strategies and alliances of the group […] Read more

 

Bionaturis shares start quoting in the continuous system on the MAB

Shares of Bionaturis (BNT-MB), an international reference company developing biological drugs, will start quoting from next 23 June in the continuous system instead of fixing (with two auctions per day) on the MAB
[…] Read more

INVESTOR INFO

Relevant Info: Operative orderRelevant info: Licences, patents and products

Relevant info: Composition of the board of Directors

Relevant info: Significant shares

Relevant info: Agreements in meetings and assembly

Relevant info: Composition of the Board of Directors

Relevant info: Significant shares

Hi, this newsletter contains information about my website. For any question, please contact to info@bionaturis.com
Imagen Boletín Bionaturis Imagen Twitter Bionaturis Imagen Linked In Bionaturis Imagen Flickr Bionaturis Imagen Youtube Bionaturis Imagen Blog Bionaturis

Este e-mail ha sido enviado por *|EMAIL|*¿Por qué me sale esto?    No quiero seguir recibiendo este newsletter    Actualizar las preferencias de suscripción

*|LIST:ADDRESSLINE|*

*|REWARDS|*